We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEL icon
76
TE Connectivity
TEL
$58.8B
$24.5M 0.42%
379,791
-71,114
-16% -$4.35M
ZBH icon
77
Zimmer Biomet
ZBH
$17.7B
$24.1M 0.42%
+190,550
New +$23.5M
LH icon
78
Labcorp
LH
$24.3B
$23.8M 0.41%
201,372
-55,612
-22% -$6.55M
AGCO icon
79
AGCO
AGCO
$8.78B
$23.4M 0.4%
474,920
-18,560
-4% -$891K
AXON
80
Axon Enterprise
AXON
$40.5B
$23.2M 0.4%
812,639
+46,815
+6% +$1.3M
ISRG icon
81
Intuitive Surgical
ISRG
$121B
$23.2M 0.4%
288,000
+22,500
+8% +$1.72M
CSCO icon
82
Cisco
CSCO
$450B
$23.2M 0.4%
730,659
+28,950
+4% +$890K
TRIP icon
83
CALL
TripAdvisor
TRIP
$1.59B
$23.1M 0.4%
+365,000
New +$23.5M
CNC icon
84
Centene
CNC
$31.3B
$22.5M 0.39%
673,000
+57,996
+9% +$2.01M
RGA icon
85
Reinsurance Group of America
RGA
$15.7B
$22.4M 0.39%
207,500
+10,000
+5% +$1.02M
CCL icon
86
Carnival Corporation Ltd
CCL
$36.1B
$22.3M 0.39%
456,857
-170,390
-27% -$7.88M
ESNT icon
87
Essent Group
ESNT
$6.06B
$22M 0.38%
825,000
+75,000
+10% +$1.9M
FIVN icon
88
FIVE9
FIVN
$1.77B
$21.9M 0.38%
1,398,199
+179,612
+15% +$2.45M
NEWR
89
DELISTED
New Relic, Inc.
NEWR
$21.8M 0.38%
567,933
+178,950
+46% +$6.29M
RVNC
90
DELISTED
Revance Therapeutics, Inc.
RVNC
$21.4M 0.37%
1,319,871
+151,329
+13% +$2.2M
COO icon
91
Cooper Companies
COO
$13.7B
$21.2M 0.37%
472,000
-48,000
-9% -$2.19M
NMBL
92
DELISTED
Nimble Storage, Inc.
NMBL
$21.1M 0.37%
2,394,557
– –
GLOB icon
93
Globant
GLOB
$1.35B
$20.8M 0.36%
493,556
+104,450
+27% +$4.27M
BSX icon
94
Boston Scientific
BSX
$65.8B
$20M 0.35%
840,000
+190,000
+29% +$4.53M
AMG icon
95
Affiliated Managers Group
AMG
$9.46B
$20M 0.34%
138,005
+9,885
+8% +$1.42M
A icon
96
Agilent Technologies
A
$39.1B
$19.8M 0.34%
+420,000
New +$19.6M
AMD icon
97
Advanced Micro Devices
AMD
$851B
$19.2M 0.33%
+2,778,420
New +$17.7M
CI icon
98
Cigna
CI
$76.6B
$19.2M 0.33%
147,055
-95,973
-39% -$12.5M
OLED icon
99
Universal Display
OLED
$3.71B
$19.1M 0.33%
344,097
+33,325
+11% +$2.11M
NOW icon
100
ServiceNow
NOW
$102B
$18.9M 0.33%
1,196,580
+353,890
+42% +$5.22M
2 3
4
5 6

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.